Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
786.77
789.80
813.64
762.76
566.28
406.32
306.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
786.77
789.80
813.64
762.76
566.28
406.32
306.34
Raw Material Cost
387.64
375.77
378.28
383.03
266.96
186.91
155.09
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
206.42
184.95
169.30
0.00
112.01
85.52
65.65
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.38
8.03
8.27
6.55
1.88
1.60
2.71
Selling and Distribution Expenses
106.15
124.62
113.55
111.09
79.22
59.40
54.54
Other Expenses
-5.85
-9.85
-10.54
5.49
-5.09
-4.12
-2.44
Total Expenditure (Excl Depreciation)
650.12
594.87
563.96
555.58
409.18
292.19
253.64
Operating Profit (PBDIT) excl Other Income
136.7
194.89999999999998
249.7
207.2
157.10000000000002
114.1
52.699999999999996
Other Income
33.97
63.17
62.53
53.79
-4.22
-5.72
19.57
Operating Profit (PBDIT)
220.96
306.39
344.12
291.94
177.97
127.76
86.36
Interest
8.38
8.03
8.27
6.55
1.88
1.60
2.71
Exceptional Items
-0.49
5.50
-4.49
4.95
13.33
-5.23
-0.32
Gross Profit (PBDT)
399.13
414.03
435.36
379.72
299.32
219.41
151.25
Depreciation
74.19
63.66
40.59
34.48
30.02
25.43
22.73
Profit Before Tax
137.90
240.20
290.76
255.86
159.39
95.50
60.60
Tax
7.33
33.41
36.86
20.48
13.46
8.66
4.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
130.57
206.79
253.90
235.38
145.93
86.84
56.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
130.57
206.79
253.90
235.38
145.93
86.84
56.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
130.57
206.79
253.90
235.38
145.93
86.84
56.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,269.36
2,271.89
2,141.58
1,461.14
1,254.82
1,126.88
645.19
Earnings per share (EPS)
0.16
0.25
0.31
0.3
0.19
0.12
0.08
Diluted Earnings per share
0.16
0.25
0.31
0.3
0.19
0.12
0.08
Operating Profit Margin (Excl OI)
14.34%
22.74%
29.62%
26.7%
26.87%
26.59%
14.38%
Gross Profit Margin
26.96%
38.47%
40.72%
38.06%
33.45%
29.76%
27.2%
PAT Margin
16.6%
26.18%
31.21%
30.86%
25.77%
21.37%
18.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -0.38% vs -2.93% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -36.85% vs -18.55% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -23.11% vs -13.64% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 5.00% vs -3.61% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Zhejiang Ausun Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
786.77
0
786.77
Other Operating Income
0.00
0.00
0.00
Total Operating income
786.77
0
786.77
Raw Material Cost
387.64
0
387.64
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
206.42
0
206.42
Power Cost
0
0
0.00
Manufacturing Expenses
8.38
0
8.38
Selling and Distribution Expenses
106.15
0
106.15
Other Expenses
-5.85
0.00
-5.85
Total Expenditure (Excl Depreciation)
650.12
0
650.12
Operating Profit (PBDIT) excl Other Income
136.65
0.00
136.65
Other Income
33.97
0
33.97
Operating Profit (PBDIT)
220.96
0
220.96
Interest
8.38
0
8.38
Exceptional Items
-0.49
0
-0.49
Gross Profit (PBDT)
399.13
0
399.13
Depreciation
74.19
0
74.19
Profit Before Tax
137.90
0
137.90
Tax
7.33
0
7.33
Provisions and contingencies
0
0
0.00
Profit After Tax
130.57
0
130.57
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
130.57
0
130.57
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
130.57
0
130.57
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,269.36
0
2,269.36
Earnings per share (EPS)
0.16
0
0.16
Diluted Earnings per share
0.16
0
0.16
Operating Profit Margin (Excl OI)
14.34%
0%
0.00
14.34%
Gross Profit Margin
26.96%
0%
0.00
26.96%
PAT Margin
16.60%
0%
0.00
16.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 78.68 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -0.38% vs -2.93% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 13.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -36.85% vs -18.55% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.70 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -23.11% vs -13.64% in Dec 2024
Annual - Interest
Interest 0.84 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.00% vs -3.61% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.34%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






